Criteria for Dose Adjustment of Tildrakizumab in Psoriasis Vulgaris
JEADV Clinical Practice, EarlyView.
Andreas Pinter+2 more
wiley +1 more source
Epidemiology of Psoriasis in Poland: Prevalence, Incidence, and Mortality Rates
ABSTRACT Background Although the data on psoriasis epidemiology included in the Global Psoriasis Atlas (GPA) provide valuable information on psoriasis prevalence worldwide, the GPA database is still incomplete. Therefore, the aim of the study was to assess the prevalence, incidence, and mortality rates of psoriasis and its types in Poland based on the ...
Joanna Bartosińska+10 more
wiley +1 more source
Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis. [PDF]
Bhushan V+11 more
europepmc +1 more source
Challenging the Dogma That Psoriasis Skin Lesions Occur Before Arthritis
ABSTRACT Background Psoriasis skin lesions are generally thought to occur before psoriatic arthritis (PsA) develops. However, PsA may be challenging to diagnose in the absence of psoriasis and might be underdiagnosed when occurring before psoriasis.
Hannah Y. Gantz+9 more
wiley +1 more source
Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis
Dario Kivelevitch, Bobbak Mansouri, Alan Menter Department of Dermatology, Baylor University Medical Center, Dallas, TX, USA Abstract: Psoriasis is a chronic, immune-mediated inflammatory disease affecting both the skin and joints.
Kivelevitch D, Mansouri B, Menter A
doaj
Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study. [PDF]
D'Angelo S+30 more
europepmc +1 more source
ABSTRACT Background Bimekizumab, a monoclonal antibody targeting interleukin (IL)‐17A and IL‐17F, has shown efficacy in psoriatic arthritis (PsA) clinical trials, but real‐world data on its effectiveness are limited. This study aimed to evaluate its real‐world effectiveness in PsA patients treated in dermatologic settings.
Giacomo Caldarola+12 more
wiley +1 more source
Muhammad Haroon,1 Oliver FitzGerald,1 Robert Winchester2 1Department of Rheumatology, St Vincent's University Hospital, Dublin, Ireland; 2Division of Rheumatology, Columbia University College of Physicians and Surgeons, New York, NY, USA Abstract ...
Haroon M, FitzGerald O, Winchester R
doaj
Decoding the Prescriber: Dermatology Versus Rheumatology Approaches
Australasian Journal of Dermatology, EarlyView.
Nicole Kah Mun Yoong+2 more
wiley +1 more source